Cancer risk assessment: Examining the family physician's role

Journal of the American Board of Family Medicine

Volumn 19, Issue 5, 2006, Pages 468-477

  Tyler Jr , Carl V ^a   Snyder, Clint W ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAMNESIS; CANCER GENETICS; CANCER RISK; CHILD; CONSULTATION; CONTROLLED STUDY; FAMILY MEDICINE; FEMALE; GENERAL PRACTITIONER; HEALTH CENTER; HUMAN; HUMAN EXPERIMENT; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; REVIEW; RISK ASSESSMENT;

EID: 33750049649     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.19.5.468     Document Type: Review

References (32)

1. Eberl MM, Sunga AY, Farrell CD, Mahoney MC. Patients with a family history of cancer: identification and management. J Am Board Fam Pract 2005;18:211-7.
2. Sifri R, Gangadharappa S, Acheson L. Identifying and testing for hereditary susceptibility to common cancers. CA Cancer J Clin 2004;54:309-26.
3. Medalie JH, Zyzanski SJ, Langa D, Stange KC. The family in family practice: is it a reality? J Fam Pract 1998;46:390-6.
4. Sifri RA, Wender R, Paynter N. Cancer risk assessment from family history: gaps in primary care practice. J Fam Pract 2002;51:856.
5. Hampel H, Sweet K, Westman JA, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004;41:81-91.
6. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003;124:544-60.
7. Pinsky PF, Kramer BS, Reding D, Buys S. Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 2003;157:792-9.
8. Strahm B, Malkin D. Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer 2006; Epub ahead of print: April 26.
9. Acheson LS, Wiesner GL, Zyzanski S, Goodwin MA, Stange KS. Family history-taking in community practice: implications for genetic screening. Genet Med 2000;2:180-5.
10. Dove-Edwin I, Sasieni P, Adams J, Thomas J. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year prospective, follow-up study. BMJ 2005;331:1047. Epub 2005 Oct 21.
11. Gennarelli M, Jandorf L, Cromwell C, Valdimarsdottir H, Redd W, Iskaowitz S. Barriers to colorectal cancer screening: inadequate knowledge by physicians. Mt Sinai J Med 2005;72:36-44.
12. Schrony PC, Barriron AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 2002;97:1031-6.
13. Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health 1995;85:795-800.
14. Tinley ST, Houfek J, Watson P, et al. Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A 2004;125:5-11.
15. Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med 2003;115:129-33.
16. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 2004;141:264-71.
17. Bampton PA, Sandford JJ, Young GP. Applying evidence-based guidelines improves use of colonoscopy resources in patients with a moderate risk of colorectal neoplasia. Med J Aust 2002;176:155-7.
18. Paskett ED, Tatum C, Rushing J, et al. Racial differences in knowledge, attitudes, and cancer screening practices among a triracial rural population. Cancer 2004;101:2650-9.
19. Hall M, Olopade O. Confronting genetic testing disparities: knowledge is power. JAMA 2005;293:1783-5.
20. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005;41:23-9.
21. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005;293:1729-36.
22. Clayton EW. Ethical, legal, and social implications of genomic medicine. N Engl J Med 2003;349:562-9.
23. Gramling R, Nash J, Siren K, Eaten C, Culpepper L. Family physician self-efficacy with screening for inherited cancer risk. Ann Fam Med 2004;2:130-2.
24. Severin MJ. Genetic susceptibility for specific cancers: medical liability of the clinician. Cancer 1999;86:1744-9.
25. Sweet K, Willis SK, Ashida S, Westman JA. Use of fear-appeal techniques in the design of tailored cancer risk communication messages: implications for healthcare providers. J Clin Oncol 2003;21:3375-6.
26. Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst 1999;25:59-66.
27. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;23:22-30.
28. Kinney AY, DeVellis BM, Skrzynia C, Millikan R. Genetic testing for colorectal carcinoma susceptibility. Cancer 2001;91:57-65.
29. McInerney-Leo A, Biesecker BB, Hadley DW, et al. BRCA1/2 testing in hereditary breast and ovarian cancer families. II: Impact on relationships. Am J Med Genet A 2005;133:165-9.
30. Madlensky L, Esplen MJ, Gallinger S, et al. Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med 2003;25:187-94.
31. Edwards A, Unigwe S, Elwyn G, Hood K. Effects of communicating individual risks in screening programmes: Cochrane systematic review. BMJ 2003;327:703-9.
32. Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin 2004;54:150-80.